Long COVID will cost the US an estimated $8 billion over just 3 years due to healthcare burden, managing symptoms and loss to the workforce
Publish Date: 2026-05-21 08:25:00
Source Domain: theconversation.com
-
Economic Burden of Long COVID: The study projects that the total economic burden of long COVID will exceed US$8 billion from 2025 to 2027.
-
Individual Cost of Long COVID: An individual suffering from long COVID may incur annual costs between $9,906 and $11,646, with productivity losses accounting for over 90% of these costs.
-
Prevalence and Symptom Persistence: Studies show that 6%-20% of COVID-19 patients develop long COVID, with longer symptom duration leading to higher total costs. Some long COVID symptoms have persisted for five to six years.
-
Lack of Treatment and Resources: There are no effective cures for long COVID, and treatment focuses on managing symptoms. There is a severe shortage of specialized treatment clinics.
-
Funding Cuts and Policy Ambiguity: Recent funding cuts to long COVID research and the absence of a clear national strategy for managing long COVID complicate the situation, alongside ambiguous public health guidelines since 2021.
